Quarterly report [Sections 13 or 15(d)]

Note 6 - Related Party Transactions (Details Textual)

v3.25.3
Note 6 - Related Party Transactions (Details Textual)
Sep. 30, 2025
Tactic Pharma, LLC [Member] | Monopar Therapeutics [Member]  
Ownership Percentage 4.10%